Publication Name	World Journal of Meta-Analysis
Manuscript ID	11291
Country	China

Received	2014-05-14 09:43
Peer-Review Started	2014-05-14 23:00
To Make the First Decision	2014-06-06 11:03
Return for Revision	2014-06-16 09:54
Revised	2014-06-25 23:29
Second Decision	2014-09-10 09:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-09-10 09:49
Articles in Press	2014-09-10 09:49
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-09-22 07:11
Typeset the Manuscript	2014-11-20 09:10
Publish the Manuscript Online	2014-12-02 12:25

ISSN	2308-3840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Meta-Analysis
Article Title	Using fluorodeoxy-D-glucose-positron emission tomography to monitor neoadjuvant chemotherapy response in sarcoma: A meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Yu-Ting Wang, Hong Pu, Long-Lin Yin and Jia-Yuan Chen
Funding Agency and Grant Number	Funding Agency Grant Number Scientific Research Subject of Health Department of Sichuan, China 070045
Corresponding Author	Yu-Ting Wang, MD, Department of Radiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, No. 32, Section 2, 1st Ring Road (West), Chengdu 610072, Sichuan Province, China. wangyuting_330@163.com
Key Words	18-fluorodeoxy-D-glucose-positron emission tomography; Sarcoma; Therapy monitoring; Meta-analysis
Core Tip	Histopathological response to neoadjuvant chemotherapy is a significant prognostic factor and could guild the following treatment for patients with sarcoma. Novel molecular imaging such as 18-fluorodeoxy-D-glucose-positron emission tomography (PET) could offer non-invasive and accurate assessment of such response in sarcoma based on our relatively large-sample statistical analysis for this relatively rare tumor. More information that clinical physicians concerned with was generated, such as recommended subgroup of patients, potential candidates for quantitative criteria of response and possible causes of false positives of PET.
Publish Date	2014-12-02 12:25
Citation	Wang YT, Pu H, Yin LL, Chen JY. Using fluorodeoxy-D-glucose-positron emission tomography to monitor neoadjuvant chemotherapy response in sarcoma: A meta-analysis. World J Meta-Anal 2014; 2(4): 212-220
URL	http://www.wjgnet.com/2308-3840/full/v2/i4/212.htm
DOI	http://dx.doi.org/10.13105/wjma.v2.i4.212

Full Article (PDF)	WJMA-2-212.pdf
Full Article (Word)	WJMA-2-212.doc
Manuscript File	11291-Review.doc
Answering Reviewers	11291-Answering reviewers.pdf
Copyright License Agreement	11291-Copyright assignment.pdf
Peer-review Report	11291-Peer review(s).pdf
Scientific Misconduct Check	11291-CrossCheck.jpg
Scientific Editor Work List	11291-Scientific editor work list.pdf